When it comes to the use of psychotropic agents in pediatric patients, it is not merely a question of extrapolating data from adults to children and adolescents; special consideration must be given to the effects of the drug on developing bodies and brains.
That is what makes this fourth edition of the Clinical Manual of Child and Adolescent Psychopharmacology so essential. Updated to include a succinct yet thorough review of the most recent evidence-based information and data-driven best treatment practices in child and adolescent psychiatry, this new volume is organized by DSM-5-TR diagnosis and offers an exhaustive analysis of the use of drugs in nine disorder categories that include depressive disorders, attention-deficit/hyperactivity disorder, autism spectrum disorder, eating disorders, and early schizophrenia and psychotic illnesses.
Each chapter includes comprehensive medication tables that allow easy reference of dosing, side effects, and tips for management as well as key points that summarize the most essential information for treating clinicians.
Whether they are clinical psychiatrists, medical students on psychiatry rotation, advanced practice providers, or pediatricians, readers will benefit from the depth of information in this indispensable desktop reference.
.png)
.png)
